US Drug Discovery and Pre-clinical Development
10 Sep 2014 - 11 Sep 2014 - Philadelphia, PA, USA
The cost of taking a drug to the market has risen rapidly over the past three decades, with an estimated development cost of $800m to $1bn for a new drug. Of 5,000 compounds that enter pre-clinical testing, only five, on average, are tested in human trials, and only one of these five receives approval for therapeutic use. It is not surprising that, while development costs have increased, the absolute number of newly approved drugs has constantly decreased for several years.